Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
TUV Rheinland India enter partnership with AP MedTec Zone to deliver medical devices - The Pharma Times | Pharma & Health Care News Portal
Categories: Latest

TUV Rheinland India enter partnership with AP MedTec Zone to deliver medical devices

Hyderabad, June 18, 2017: TUV Rheinland India, a subsidiary of TUV Rheinland Group, Germany, a worldwide leader in Testing, Training, Inspection, Consulting and Certification, announced today that it has partnered with Andhra Pradesh MedTech Zone(AMTZ), the country’s first Medical Technology Manufacturing Park.
MTZ was recently established at Visakapatnam over an area of 270 acres by the Government of Andhra Pradesh.
As per the terms of the partnership, TUV Rheinland India has been awarded a contract to set up and operate Electro-Magnetic Interference (EMI/EMC) including Anechoic Chambers, Biomaterial, Reliability and Electrical Safety Testing Facilities on Public Private Partnership Mode within AMTZ at an estimated investment of about Rs 85 crore over 4-5 years to support AMTZ’s objective to reduce medical device imports and production cost, partner with industry to deliver the quality medical devices to local market and eventually increase the export of world class medical devices to the international market, a release said here.
The contract was signed by Mr. Thomas Fuhrmann, Managing Director of TUV Rheinland India and Dr.Jitendar Kumar Sharma, Director and CEO of AMTZ.
The creation of AMTZ is based on the fact that medical devices manufacturing requires very high investment facilities which are capital intensive for individual manufacturers to invest upon. With a market size of close to 4 Billion dollars,78 per cent of medical devices in India are imported from other countries, the release said.
AMTZ will house modern 250-300 independent manufacturing units,each over a built-in ready to use area at a very cost effective long-term lease.In addition, the park will have in-house high investment scientific facilities, including state-of-the-art testing laboratories, which would help manufacturers significantly reduce the cost manufacturing thereby creating world class diagnosis with quality products accessible to the common man at affordable prices.

United News of India

The Pharma Times News Bureau

Recent Posts

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

5 days ago

Milestone set in Indian Medical History – SSI Mantra Surgical Robotic System Performs the First-Ever Successful Surgery on One-Year-Old Infant

SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…

1 week ago

Manipal Hospital Ghaziabad organises Fire Safety Training to Enhance Emergency Response

Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…

2 weeks ago

Professor Dr Robert Zeiser receives DKMS Mechtild Harf Science Award 2024

DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…

3 weeks ago

Dr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India

Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…

3 weeks ago

Ankura Hospital Doctors perform a successful Complex Lung Surgery on a 4-month-old Infant

 Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…

3 weeks ago